- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
Making Sense Of the Sahel When Washington Can’t
For nearly twenty-five years, Washington has quietly expanded America’s Global War on Terror across Africa. Today, U.S. military activities stretch from the Horn of Africa through the Sahel to the Atlantic coast, encompassing intelligence bases, drone operations,...
